Once-daily aminoglycoside dosing. 1993

P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño

UI MeSH Term Description Entries
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004427 Ear Diseases Pathological processes of the ear, the hearing, and the equilibrium system of the body. Otologic Diseases,Otological Diseases,Disease, Ear,Disease, Otologic,Disease, Otological,Ear Disease,Otologic Disease,Otological Disease
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
July 1997, American family physician,
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
April 1993, Lancet (London, England),
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
April 1993, Lancet (London, England),
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
April 1993, Lancet (London, England),
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
February 1993, Lancet (London, England),
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
May 1996, The Medical journal of Australia,
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
February 1997, Annals of internal medicine,
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
January 1993, The Journal of antimicrobial chemotherapy,
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
June 2000, Infectious disease clinics of North America,
P Gonzalez, and J M Aguado, and M A Martin, and T Fernandez-Chacon, and B Ortuño
May 1991, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!